Investment Analysts’ Updated EPS Estimates for February 10th (AARD, AAUC, AMAT, APO, ARE, ARWR, AVXL, BDX, BKNG, BR)

Investment Analysts’ updated eps estimates for Tuesday, February 10th:

Aardvark Therapeutics (NASDAQ:AARD) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $26.00 price target on the stock.

Allied Gold (NYSE:AAUC) was downgraded by analysts at Stifel Nicolaus from a buy rating to a hold rating.

Applied Materials (NASDAQ:AMAT) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $385.00 target price on the stock.

Apollo Global Management (NYSE:APO) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $165.00 price target on the stock.

Alexandria Real Estate Equities (NYSE:ARE) had its sector perform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $60.00 target price on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $100.00 price target on the stock.

Anavex Life Sciences (NASDAQ:AVXL) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $20.00 price target on the stock.

Barclays PLC assumed coverage on shares of Becton, Dickinson and Company (NYSE:BDX). Barclays PLC issued an overweight rating and a $202.00 target price on the stock.

Booking (NASDAQ:BKNG) was upgraded by analysts at Gordon Haskett from a hold rating to a buy rating. Gordon Haskett currently has $5,440.00 target price on the stock.

Broadridge Financial Solutions (NYSE:BR) had its buy rating reissued by analysts at DA Davidson. DA Davidson currently has a $228.00 price target on the stock.

Blackstone Mortgage Trust (NYSE:BXMT) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $23.00 price target on the stock.

Cango (NYSE:CANG) had its buy rating reissued by analysts at HC Wainwright. They currently have a $3.00 price target on the stock.

Stifel Nicolaus started coverage on shares of Ceva (NASDAQ:CEVA). Stifel Nicolaus issued a buy rating and a $30.00 target price on the stock.

Chegg (NYSE:CHGG) had its hold rating reissued by analysts at Needham & Company LLC.

Columbus McKinnon (NASDAQ:CMCO) had its neutral rating reaffirmed by analysts at DA Davidson. They currently have a $15.00 target price on the stock.

Dynatrace (NYSE:DT) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $68.00 target price on the stock.

Estee Lauder Companies (NYSE:EL) was downgraded by analysts at HSBC Holdings plc from a buy rating to a hold rating. They currently have $106.00 target price on the stock.

Enanta Pharmaceuticals (NASDAQ:ENTA) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $20.00 target price on the stock.

E.On (OTCMKTS:EONGY) was downgraded by analysts at Berenberg Bank from a buy rating to a hold rating.

European Wax Center (NASDAQ:EWCZ) was downgraded by analysts at Truist Financial Corporation from a buy rating to a hold rating. They currently have $5.80 price target on the stock.

Janney Montgomery Scott assumed coverage on shares of Glacier Bancorp (NASDAQ:GBCI). They issued a neutral rating and a $55.00 target price on the stock.

Graham (NYSE:GHM) was upgraded by analysts at Northland Securities from a market perform rating to an outperform rating.

Generac (NYSE:GNRC) had its buy rating reiterated by analysts at Guggenheim. They currently have a $202.00 target price on the stock.

ZoomInfo Technologies (NASDAQ:GTM) was downgraded by analysts at Citizens Jmp from a market perform rating to a mkt underperform rating. They currently have $6.00 target price on the stock.

Ichor (NASDAQ:ICHR) was upgraded by analysts at B. Riley Securities from a neutral rating to a buy rating. They currently have $52.00 price target on the stock, up from their previous price target of $30.00.

Immunovant (NASDAQ:IMVT) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $35.00 target price on the stock.

IREN (NASDAQ:IREN) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $70.00 price target on the stock.

Jerash Holdings (US) (NASDAQ:JRSH) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $4.00 price target on the stock.

Kodiak Sciences (NASDAQ:KOD) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $38.00 price target on the stock.

Kroger (NYSE:KR) had its buy rating reiterated by analysts at Guggenheim. They currently have a $78.00 target price on the stock.

Knightscope (NASDAQ:KSCP) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $12.00 price target on the stock.

Linde (NASDAQ:LIN) was downgraded by analysts at DZ Bank AG from a buy rating to a hold rating. The firm currently has $460.00 price target on the stock.

B. Riley Securities assumed coverage on shares of Microbot Medical (NASDAQ:MBOT). The firm issued a buy rating and a $5.00 target price on the stock.

Spectral AI (NASDAQ:MDAI) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $3.00 price target on the stock.

Nektar Therapeutics (NASDAQ:NKTR) was upgraded by analysts at William Blair from a market perform rating to an outperform rating.

Nuvation Bio (NYSE:NUVB) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $11.00 target price on the stock.

ON Semiconductor (NASDAQ:ON) was downgraded by analysts at Benchmark Co. from a buy rating to a hold rating.

ON Semiconductor (NASDAQ:ON) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $60.00 target price on the stock.

Chardan Capital began coverage on shares of Passage Bio (NASDAQ:PASG). The firm issued a buy rating and a $21.00 price target on the stock.

PDF Solutions (NASDAQ:PDFS) had its buy rating reissued by analysts at DA Davidson. They currently have a $36.00 price target on the stock.

Phio Pharmaceuticals (NASDAQ:PHIO) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $14.00 price target on the stock.

Palantir Technologies (NASDAQ:PLTR) was upgraded by analysts at Daiwa Securities Group Inc. from a neutral rating to a buy rating. They currently have $180.00 price target on the stock.

Peloton Interactive (NASDAQ:PTON) was downgraded by analysts at Argus from a buy rating to a hold rating.

uniQure (NASDAQ:QURE) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $70.00 price target on the stock.

Bank of America Corporation began coverage on shares of Remitly Global (NASDAQ:RELY). Bank of America Corporation issued a buy rating and a $18.00 target price on the stock.

Southern First Bancshares (NASDAQ:SFST) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Stephens began coverage on shares of Somnigroup International (NYSE:SGI). Stephens issued an equal weight rating and a $89.00 price target on the stock.

Sangamo Therapeutics (NASDAQ:SGMO) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $10.00 price target on the stock.

Sirius XM (NASDAQ:SIRI) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. JPMorgan Chase & Co. currently has $24.00 price target on the stock.

TD SYNNEX (NYSE:SNX) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Protara Therapeutics (NASDAQ:TARA) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $23.00 price target on the stock.

Take-Two Interactive Software (NASDAQ:TTWO) was upgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a strong-buy rating. The firm currently has $285.00 target price on the stock.

Unity Software (NYSE:U) was upgraded by analysts at Oppenheimer Holdings, Inc. from a market perform rating to an outperform rating. Oppenheimer Holdings, Inc. currently has $38.00 target price on the stock.

Frontier Group (NASDAQ:ULCC) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating. They currently have $6.00 target price on the stock.

Upwork (NASDAQ:UPWK) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $25.00 price target on the stock.

VinFast Auto (NASDAQ:VFS) had its buy rating reiterated by analysts at Chardan Capital. The firm currently has a $5.50 price target on the stock.

Evercore ISI initiated coverage on shares of Waters (NYSE:WAT). They issued an in-line rating and a $360.00 price target on the stock.

Citigroup Inc. initiated coverage on shares of Waters (NYSE:WAT). They issued a buy rating and a $425.00 price target on the stock.

Waters (NYSE:WAT) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $440.00 price target on the stock.

Warby Parker (NYSE:WRBY) had its outperform rating reissued by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $32.00 price target on the stock.

Zimmer Biomet (NYSE:ZBH) had its hold rating reissued by analysts at Needham & Company LLC.

Zenas BioPharma (NASDAQ:ZBIO) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $44.00 price target on the stock.

Receive News & Ratings for Aardvark Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aardvark Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.